Results from a cross-sectional study of 116,816 patients.
Few data have been available to guide therapy.
Advice has been published by the Scottish Medicines Consortium.
Infection is the leading cause of discontinuation of systemic therapies.
Two new studies in JAMA Dermatology explore the association between psoriasis and mental health disorders.
Data from 7 randomized controlled trials.
The technology measures the sub-epidermal moisture to determine the likelihood of developing pressure ulcers.
Product contains hyaluronic acid with glycoprotein and peptide glycan complex.
Data from a small randomized trial.
Real-world data show higher discontinuation rate than methotrexate.
Co-existence of both conditions are almost exclusively ANA-negative and linked to better prognosis.
Initial lower efficacy observed.
A useful method for identifying underexposed patients.
Results from the QSkin Sun and Health Study.
The comorbidity burden of patients with HS has not been systematically studied.
First study linking IGA severity and PROs in real-world setting.
Drugs suitable for patients with PASI ≥10 and DLQI >10.
